QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gauvreau, Gail M
  • Boulet, Louis-Philippe
  • Leigh, Richard
  • Cockcroft, Donald W
  • Davis, Beth E
  • Mayers, Irvin
  • FitzGerald, J Mark
  • Dahlen, Barbro
  • Watson, RM
  • Milot, Joanne
  • Swystun, Veronica
  • Hui, Linda
  • Lantz, Ann-Sofie
  • Bowen, Miranda
  • Arm, Jonathan
  • Maahs, Suzzane
  • Meiser, Karin
  • Lowe, Philip
  • Skerjanec, Andrej
  • Carlsten, Christopher
  • Strandberg, Karin
  • Killian, Kieran J
  • Laviolette, Michele
  • Drollmann, Anton
  • O'Byrne, Paul

publication date

  • September 2015